Foster Wheeler Awarded Contract By Kedrion Group In Hungary
Foster Wheeler AG's Global Engineering and Construction Group has been awarded by Kedrion Group and its Hungarian-controlled Human Bioplazma LLC. a contract for engineering, procurement, construction management and commissioning/qualification supervision for the upgrading and expansion of a bulk plasma fractionation manufacturing facility at Gödöllö, Hungary.
Kedrion is a biopharmaceutical company specialising in the development, manufacture and distribution of plasma-derived medicinal products.
The contract consists of the upgrading and capacity expansion of an existing plasma fractionation plant in line with Good Manufacturing Practice (GMP), including the installation of a new production line. During the upgrading works, the existing line will remain in operation. The plant is expected to be completed in the first quarter of 2011.
"We are very pleased to assign the execution of such an important project to Foster Wheeler," said Rodolfo Franceschini, global operations director of Kedrion Group. "The strong cooperation between Foster Wheeler and Kedrion Group has been developing as a real partnership, aimed to get the target."
Find out more about:
Foster Wheeler »
Search for more News